|
"blanc jean frederic"的相关文件
显示项目 1-3 / 3 (共1页)
1
每页显示[10|25|50]项目
| 國立成功大學 |
2016-10 |
Phase II Studies with Refametinib or Refametinib Plus Sorafenib in Patients with Mutant RAS Hepatocellular Carcinoma (HCC)
|
Llovet, Josep M.;Merle, Philippe;Weiss, Karl Heinz;Yau, Thomas;Ross, Paul;Mazzaferro, Vincenzo;Blanc, Jean-Frederic;Ma, Yuk T.;Yen, Chia Jui;Kocsis, Judit;Choo, Su Pin;Sukeepaisarnjaroen, Watana;Gerolami, Rene;Dufour, Jean -Francois;Gane, Edward J.;Ryoo, Baek-Yeol;Peck-Radosavljevic, Markus;Dao, Thong;Yeo, Winnie;Lamlertthon, Wisut;Thongsawat, Satawat;Teufel, Michael;Krissel, Heiko;Lim, Ho Yeong |
| 國立成功大學 |
2016-02-01 |
Updated overall survival analysis of NAPOLI-1: Phase III study of nanoliposomal irinotecan (nal-IRI, MM-398), with or without 5-fluorouracil and leucovorin (5-FU/LV), versus 5-FU/LV in metastatic pancreatic cancer (mPAC) previously treated with gemcitabine-based therapy.
|
Wang-Gillam, Andrea;Li, Chung-Pin;Bodoky, Gyorgy;Dean, Andrew;Shan, Yang-Shen;Jameson, Gayle S.;Macarulla, Teresa;Lee, Kyung-Hun;Cunningham, David;Blanc, Jean-Frederic;Hubner, Richard;Chiu, Chang-Fang;Schwartsmann, Gilberto;Siveke, Jens T.;Braiteh, Fadi S.;Moyo, Victor M.;Belanger, Bruce;Bayever, Eliel;Von Hoff, Daniel D.;Chen, Li-Tzong |
| 國立成功大學 |
2014-07-02 |
Effect of Everolimus on Survival in Advanced Hepatocellular Carcinoma After Failure of Sorafenib The EVOLVE-1 Randomized Clinical Trial
|
Zhu, Andrew X.; Kudo, Masatoshi; Assenat, Eric; Cattan, Stephane; Kang, Yoon-Koo; Lim, Ho Yeong; Poon, Ronnie T. P.; Blanc, Jean-Frederic; Vogel, Arndt; Chen, Chao-Long; Dorval, Etienne; Peck-Radosavljevic, Markus; Santoro, Armando; Daniele, Bruno; Furuse, Junji; Jappe, Annette; Perraud, Kevin; Anak, Oezlem; Sellami, Dalila B.; Chen, Li-Tzong |
显示项目 1-3 / 3 (共1页)
1
每页显示[10|25|50]项目
|
